Tosoh Bioscience GmbH
Im Leuschnerpark 4
64347 Griesheim, Deutschland

Tel: +49 6155-7043700
Fax: +49 6155-8357900

Based on the track record of the Tosoh BioSeparation Forum series of events we created a virtual event packed with inspiring presentations, scientific updates and opportunities to connect with your peers. The virtual BioSeparation Forum will present an overview on the use of bio-chromatography for manufacturing and analysis of specific target molecules in two streams:

  • Manufacturing - New Therapies & Antibodies 
  • Analytics - Speed & Accuracy

You have the possibility to register for each lecture individually or directly for an entire session. Each section will conclude with a joint Q & A session with the presenters form academia, biopharma and Tosoh. If you register for an entire session, you automatically participate in the Q & A session.

Gain insights into chromatography, new therapies,
and antibody manufacturing & characterization

BioSeparation Forum – October 1, 2020

Session 1: Manufacturing - New Therapies & Antibodies

9:00 - 9:15


Tosoh Bioscience

9:15 - 9:45

Development of production processes for vaccines and viral vectors

Michael W. Wolff | University of Applied Sciences Mittelhessen, Giessen, Germany

Find out moreRegister for session 1

9:45 - 10:15

Tackling the capacity bottleneck in downstream processing of viral vectors

Kai Touw | Batavia Biosciences

10:15 - 10:30

Live Discussion/Q+A New Therapies

10:45 - 11:15

Process intensification by parallel, flow through chromatography and counter current chromatography

Alois Jungbauer | BOKU University of Natural Resources and Life Sciences Vienna

11:15 - 11:45

Reduce downstream processing cost for mAbs by using a 2-step plattform

Romain Dabre | Tosoh Bioscience GmbH

11:45 - 12:15

Approaches enabling antibody manufacturing at pandemic speed

Anja Trapp | Rentschler Biopharma

12:15 - 12:30

Live Discussion/Q+A Antibodies

14:00 - 14:30

SEC-MS; considerations when adding this extra dimension to your protein characterization workflow

Rob Haselberg | Vrije Universiteit Amsterdam, Amsterdam

14:30 - 15:00

A new chromatographic approach to quickly asses glycan profiles in process development

Marcel Nowak & Stephan Schultz |  UGA Biopharma

15:00 - 15:30

The generic SEC method in a global company

Alex Knaupp | Roche Diagnostics GmbH

15:30 - 16:00

LenS3 –MALS Technology for next generation biopharmaceuticals

Patrick Endres | Tosoh Bioscience GmbH

16:00 - 16:30

Live Discussion/Q+A Analytics

Session 2: Analytics - Speed & Accuracy

Find out moreFind out moreFind out moreFind out moreFind out moreFind out moreFind out moreFind out more

Please click here to register for the entire Session 1 
Manufacturing - New Therapies & Antibodies

Register for session 2

Please click here to register for the entire Session 2 
Analytics - Speed & Accuracy